Status:
COMPLETED
Evaluation of Respiratory Parameters in Patients With Upper Limb Lymphedema
Lead Sponsor:
Istanbul University - Cerrahpasa
Collaborating Sponsors:
Okan University
Conditions:
Lymphedema of Upper Limb
Eligibility:
FEMALE
25-65 years
Brief Summary
The aim of our study is to assess disease severity, respiratory muscle strength, respiratory functions, pectoralis minor muscle shortening, functionality, and quality of life (QoL) in patients with up...
Detailed Description
The study had a cross-sectional observational study design. The participants were divided into two groups, patients with ULL in Group 1; the healthy individuals were included in Group 2. All assessmen...
Eligibility Criteria
Inclusion
- aged 25-65 years with secondary, unilateral upper limb lymphedema in Phase 2 of the protection stage,
- wearing compression garments,
- who have not received manual lymph drainage (MLD) therapy in the last 3 months
- along with healthy controls of a similar age who volunteered to participate.
Exclusion
- being in Phase 1 of lymphedema treatment (the edema-reducing phase),
- being classified as NYHA Class III and/or IV according to the New York Heart Association classification system,
- having a chronic respiratory disease,
- presence of active infection (such as lymphangitis or cellulitis), or undergoing radiotherapy/chemotherapy due to breast cancer.
Key Trial Info
Start Date :
November 20 2023
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 20 2024
Estimated Enrollment :
82 Patients enrolled
Trial Details
Trial ID
NCT06568978
Start Date
November 20 2023
End Date
August 20 2024
Last Update
August 23 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Gamze Aydın
Tuzla, Istanbul, Turkey (Türkiye), 34940